|Previous Section||Index||Home Page|
Mr. Boateng: Government policy is to stimulate enterprise and entrepreneurship in its various forms, and not to support one group of businesses over another. Both incorporation and non-incorporation offer a range of benefits to small businesses. The choice as to whether to incorporate or not is influenced by multiple factors, many of which are firm-specific, for example the personal circumstances of the owner(s). The Government take the view that businesses themselves are best placed to assess the relative benefits of different legal structures, and to decide which is most appropriate for them.
Mr. Boateng: The Government introduced a 150 per cent. accelerated payable tax credit in Budget 2001 for owners and investors for the costs they incur in cleaning up contaminated sites. This measure will make the development of these sites more viable. There are no other differences in the tax treatment of brownfield and greenfield sites.
9 May 2002 : Column 344W
Dawn Primarolo: As part of the on-going consultation about the proposed new child tax credit and working tax credit and to inform debate on the Tax Credits Bill, copies of a number of draft statutory instruments have today been placed in the Libraries of both Houses. A memorandum has been prepared by the Inland Revenue and the Department for Work and Pensions to accompany these drafts, copies of which have also been placed in the Libraries.
The draft statutory instruments have been prepared by the Inland Revenue and the Department for Work and Pensions. Together they contain proposals for the definition of income for the purposes of the new tax credits, detailed rules about entitlement to those credits and their proposed structure, and the arrangements for paying the credits to claimants. They also set out proposed changes to social security legislation in consequence of the introduction of the new credits.
Dr. Evan Harris: To ask the Secretary of State for Health, pursuant to his answer to the hon. Member for South Derbyshire (Mr. Todd) on 11 March 2002, Official Report, column 806W, if he will publish the report commissioned from Professor Protti by the Information Policy Unit and the NHS Information Authority on issues of implementing "Information for Health". 
Mr. Hutton: The report from Professor Protti is still under consideration. It is informing the preparation of the delivery plan for information and information technology that the Department is preparing as part of taking forward "Delivering the NHS Plan", published in April 2002. Professor Protti's report will be published later in the year.
Mr. Cummings: To ask the Secretary of State for Health what cash allocations have been made under the reforming emergency care accident and emergency nurse allocation for 200203 to each acute NHS trust in the northern region; upon what basis the allocations have been made; and which trusts are involved in PFI programmes. 
9 May 2002 : Column 345W
Jacqui Smith: The Performance Assessment Framework is based on a balanced scorecard, which allows organisations to get a rounded view of performance. The framework highlights a number of areas of performance, including patient/carer experience.
The framework is supported by a set of national NHS performance indicators. The indicators published in February 2002 included a number of measures of patient/carer experience, including an indicator of hospital cleanliness and information on the handling of complaints. We are currently developing indicators to reflect patients' views, based on comprehensive surveys, initially of acute in-patients, on food and other issues that are of importance to them.
Mr. Hutton: Audited health authority finance returns for the years 1999 to 2001 show that a total of £661 million was spent on general medical services primary care premises in that period. Spend on premises used by personal medical services pilot providers is not identified in these returns.
Mr. Bercow: To ask the Secretary of State for Health what estimate he has made of the total savings to public funds of the Private Finance Initiative contract for the Fulbourn School of Nursing by comparison with a non-Private Finance Initiative alternative. 
Mr. Hutton: The business case justifying the individual schemes estimating the net savings in present value terms (ie all future costs and benefits discounted to their present values) compared with publicly funding the scheme is shown in the table.
|Trusts||Eastern regional office/Fulbourn|
|Savings in net present value terms (£000)||5,805|
9 May 2002 : Column 346W
Adam Price: To ask the Secretary of State for Health (1) what representations his Department has received from (a) Generics UK, (b) Kent Pharmaceuticals, (c) Regent- GM Laboratories, (d) Goldshield Group, (e) Norton Healthcare and (f) Ranbaxy UK regarding generic drugs in the past five years; 
Mr. Hutton: As part of routine business the Department meets with pharmaceutical industry trade associations and individual pharmaceutical companies including Generics UK Ltd., Kent Pharmaceuticals Ltd., Regent-GM Laboratories Ltd., Goldshield Group Plc, Norton Healthcare Ltd. (a subsidiary of Ivax Corporation) and Ranbaxy (UK) Ltd. (a subsidiary of Ranbaxy Laboratories Ltd.) on a regular basis to discuss a range of issues including those relating to licence applications; product safety issues; leaflets and labelling and intellectual property.
In April 2000 the Government introduced a maximum price scheme for controlling the price of specified generic medicines. This was rolled forward in October 2001 and has resulted in annual savings in expenditure of generic medicines in the order of £330 million. In addition, in July 2001 the Department issued a consultation paper on proposals for NHS controls over the future supply and pricing of NHS generic medicines. In compliance with best practice these initiatives required that information and opinions be sought from those companies and organisations affected by the Department's initiatives. Accordingly officials met with and received representations from many interested parties, including Generics UK, Kent Pharmaceuticals, Regent-GM Laboratories, Norton Healthcare/Ivax and Ranbaxy UK.
Lembit Öpik: To ask the Secretary of State for Health how many unfilled vacancies for occupational therapists there are in each health authority in England and Wales; and if he will make a statement. 
|Three month vacancy:||Staff in post:|
|Northern and Yorkshire||4.6||70||1,430||1,640|
|County Durham and Darlington HA||3.6||0||80||90|
|East Riding and Hull HA||6.7||10||100||110|
|Gateshead and South Tyneside HA||5.7||10||80||90|
|Newcastle and North Tyneside HA||2.2||0||110||120|
|North Cumbria HA||6.3||0||60||70|
|North Yorkshire HA||1.2||0||160||210|
|Calderdale and Kirklees HA||2.5||0||150||170|
|North Derbyshire HA||4.0||0||100||120|
|Southern Derbyshire HA||0.7||0||140||170|
|North Nottinghamshire HA||2.5||0||80||90|
|South Humber HA||13.0||0||20||20|
|North Staffordshire HA||5.5||10||130||150|
|South Staffordshire HA||5.1||10||90||110|
|South Lancashire HA||2.5||0||70||100|
|Morecambe Bay HA||0.0||0||70||90|
|St. Helens and Knowsley HA||2.8||0||50||50|
|Salford and Trafford HA||0.7||0||140||160|
|West Pennine HA||(28)||(28)||(28)||(28)|
|Bury and Rochdale HA||5.4||0||50||60|
|North Cheshire HA||2.7||0||90||100|
|South Cheshire HA||1.0||0||90||130|
|East Lancashire HA||4.8||10||100||120|
|North West Lancashire HA||4.8||10||150||180|
|Wigan and Bolton HA||3.7||10||130||150|
|North Essex HA||1.4||0||210||250|
|South Essex HA||2.2||0||130||150|
|East and North Hertfordshire HA||4.2||0||50||60|
|West Hertfordshire HA||4.1||0||60||80|
|Kensington, Chelsea and Westminster HA||2.8||0||140||150|
|Enfield and Haringey HA||0.0||0||120||140|
|Redbridge and Waltham Forest HA||7.7||10||100||110|
|Bexley and Greenwich HA||10.7||10||80||100|
|Kingston and Richmond HA||0.0||0||60||80|
|Lambeth, Southwark and Lewisham HA||10.3||30||230||250|
|Merton, Sutton and Wandsworth HA||4.9||10||200||240|
|Barking and Havering HA||10.0||10||110||120|
|Brent and Harrow HA||12.9||10||70||80|
|Camden and Islington HA||6.2||10||150||170|
|Ealing, Hammersmith and Hounslow HA||6.6||10||190||220|
|East London and The City HA||8.2||20||140||150|
|East Kent HA||1.1||0||170||200|
|West Kent HA||9.2||20||160||200|
|East Surrey HA||2.4||0||120||140|
|West Surrey HA||7.2||10||170||210|
|East Sussex, Brighton and Hove HA||3.1||10||170||200|
|West Sussex HA||5.3||10||170||210|
|North and Mid Hampshire HA||0.9||0||70||90|
|Portsmouth and South East Hampshire HA||2.8||0||90||110|
|Southampton and South West Hampshire HA||0.8||0||120||150|
|Isle of Wight HA||16.4||0||20||20|
|South and West Devon HA||1.9||0||160||180|
|Cornwall and Isles of Scilly HA||0.0||0||90||110|
|North East and Devon HA||0.6||0||160||200|
(26) Vacancy and staff in post numbers are rounded to the nearest 10.
(27) Figures where sum of staff in post and vacancies is less than 10.
(28) Figures where previously published, where the trusts have advised that the figures supplied were incorrect.
1. Three month vacancies are vacancies as at 31 March 2001 which trusts are actively trying to fill, which had lasted for three months or more (whole time equivalents).
2. Three month vacancy rates are three month vacancies expressed as a percentage of three month vacancies plus staff in post from the September 2000 medical and dental and non-medical work force censuses (whole time equivalent).
3. Percentages are rounded to one decimal place.
4. Totals may not equal sum of component parts due to rounding.
5. HA figures are based on trusts, and do not necessarily reflect the geographical provision of health care.
6. Due to the way vacancy data have been collected it has sometimes been necessary to provide combined vacancy data information for certain trusts.
7. Due to combined vacancy data being used and rounding calculating the vacancy rates using the above data may not equal the actual vacancy rates.
8. Figures may not match previously published data due to a different method of rounding used on the staff in post data.
9 May 2002 : Column 349W
|Next Section||Index||Home Page|